← Back
$EIKN All transactions

Eikon Therapeutics, Inc.

C

$ Value

Shares

2,387,705

Price

Filed

Feb 6

Insider

Name

Lux Venture Partners V, LLC

Title

CIK

0001698118

Roles

10% Owner

Transaction Details

Transaction Date

2026-02-06

Code

C

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

2,387,705

Footnotes

These shares are held by Lux Co-Invest Opportunities II, L.P. ("LCIO II"). Lux Co-Invest Partners II, LLC ("LCIP II") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and Josh Wolfe, a member of the Issuer's board of directors (the "Individual Lux Managers"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein. | These shares are held by Lux Total Opportunities, L.P. ("LTO"). Lux Total Opportunities Partners, LLC ("LTOP") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. | The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") on a 1-for-7.4578 basis and had no expiration date. | The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. | These shares are held by Lux Ventures V, L.P. ("LVV"). Lux Venture Partners V, LLC ("LVPV") is the general partner of LVV and exercises voting and dispositive power over the shares noted herein held by LVV. The Individual Lux Managers are the individual managing members of LVPV. The Individual Lux Managers, as the sole managers of LVPV, may be deemed to beneficially own the shares held by LVV. Each of LVPV and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein. | The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. | The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. | The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. | The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. | The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date.

Filing Info

Accession No.

0001193125-26-041544

Form Type

4

Issuer CIK

0001861123

Lux Venture Partners V, LLC's History

Date Ticker Type Value
2026-02-06 EIKN C
2026-02-06 EIKN C
2026-02-06 EIKN C
2026-02-06 EIKN C
2026-02-06 EIKN C
2026-02-06 EIKN C
2026-02-06 EIKN C
2026-02-06 EIKN C
2026-02-06 EIKN C
2026-02-06 EIKN C

Other Insiders at EIKN (90d)

Insider Bought Sold Last
Column Group IV GP, LP $38.1M 2026-02-06
Lux Venture Partners V, LLC $5.0M 2026-02-06
Wolfe Josh $5.0M 2026-02-06
FRAZIER KENNETH C $2.0M 2026-03-02
Foresite Capital Management IV, LLC $1000K 2026-02-04
PERLMUTTER ROGER M
See remarks
2026-03-02
Baynes Roy D.
Chief Medical Officer
2026-03-02
Huffines Robert Luther 2026-03-02
Klobuchar Michael A
Chief Operating Officer
2026-03-02
Thorner Benjamin Bruno
See Remarks
2026-03-02
Bowie Alfred Lloyd Jr.
Chief Financial Officer
2026-03-02